[Hemostatic effects of menaquinone-4 (K2) on various types of hemorrhagic diathesis in rats and comparison with other hemostatic agents].
D000323:Adrenochrome / Q000627:therapeutic use; D000614:Aminocaproates / Q000627:therapeutic use; D000818:Animals; D000933:Antifibrinolytic Agents; D002252:Carbon Tetrachloride Poisoning / Q000150:complications; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D001728:Dicumarol / Q000037:antagonists & inhibitors; D005021:Ethylamines / Q000627:therapeutic use; D005163:Factor Analysis, Statistical; D006474:Hemorrhagic Disorders / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D006490:Hemostatics; D006873:Hydroquinones / Q000627:therapeutic use; D008297:Male; D010636:Phenols / Q000494:pharmacology; D051381:Rats; D012664:Semicarbazones / Q000627:therapeutic use; D013451:Sulfonic Acids / Q000627:therapeutic use; D014812:Vitamin K / Q000627:therapeutic use*; D010837:Vitamin K 1 / Q000627:therapeutic use
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D005021:Ethylamines; D006490:Hemostatics; D006873:Hydroquinones; D010636:Phenols; D012664:Semicarbazones; D013451:Sulfonic Acids; D014812:Vitamin K; D000323:Adrenochrome; D001728:Dicumarol; D010837:Vitamin K 1